Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Cord Blood and HPDSC in Neonates With Severe HIE
NCT02434965Phase 2Withdrawn
- Sponsor
- New York Medical College
- Start
- Dec 2019
- Primary completion
- Jan 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of PSC-100 in hypoxic-ischemic encephalopathy (HIE), sponsored by New York Medical College. Planned start Dec 2019; status: withdrawn.
02
Drugs
PSC-100
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT02434965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434965.